Baksi, A., Kraydashenko, O., Zalevkaya, A., Stets, R., Elliott, P., Haddad, J., . . . Jacobson, E. W. (2014). A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. Blackwell Science Inc.
Citação norma ChicagoBaksi, Arun, Oleg Kraydashenko, Alsu Zalevkaya, Roman Stets, Peter Elliott, Jonathan Haddad, Ethan Hoffmann, George P. Vlasuk, and Eric W. Jacobson. A Phase II, Randomized, Placebo-controlled, Double-blind, Multi-dose Study of SRT2104, a SIRT1 Activator, in Subjects With Type 2 Diabetes. Blackwell Science Inc, 2014.
MLA citiranjeBaksi, Arun, et al. A Phase II, Randomized, Placebo-controlled, Double-blind, Multi-dose Study of SRT2104, a SIRT1 Activator, in Subjects With Type 2 Diabetes. Blackwell Science Inc, 2014.